The batch production and control records are deficient in that they do not include a statement of the actual yield and percentage of theoretical yield.
Inspection Record
Paxeuticals LLC — FDA 483 Findings
Inspectors Yvins DezanThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent malfunctions, contamination, that would alter the safety, identity, strength, quality or purity of the drug product.
Drug products are not stored under appropriate conditions oftemperature, humidity, and light so that their identity, strength, quality, and purity are not affected.
The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Instituto Grifols, S.A.2023-11-17 · US FDASimilar to finding 5 Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity…
- Merck Teknika LLC2024-11-27 · US FDASimilar to finding 6 Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use.
- Bello Bio LLC2025-12-16 · US FDASimilar to finding 5 Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength…
- IntegraDose Compounding Services LLC2018-09-19 · US FDASimilar to finding 4 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- Akorn Inc.2018-08-30 · US FDASimilar to finding 4 The responsibilities and procedmes applicable to the quality control unit are not in writing and fully followed.
A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.